Topical treatments for eczema
Pro Research Analysisby 
Searched over 200M research papers
Topical Anti-Inflammatory Treatments for Eczema: Corticosteroids, Calcineurin Inhibitors, and New Agents
Topical corticosteroids (TCS) remain the mainstay of eczema treatment, especially for managing flares. Potent and moderate TCS are generally more effective than mild TCS, particularly in moderate or severe cases, but there is little evidence that very potent TCS are better than potent ones. Once-daily application of potent TCS is as effective as twice-daily use, and proactive weekend therapy can help prevent relapses. Short-term use of TCS rarely causes skin thinning, but the risk increases with higher potency and longer-term use. Topical calcineurin inhibitors (TCI), such as tacrolimus and pimecrolimus, are effective alternatives, especially for sensitive areas like the face and skin folds, and are also used for proactive therapy. Newer agents, including Janus kinase (JAK) inhibitors and phosphodiesterase-4 (PDE-4) inhibitors, are emerging options, but PDE-4 inhibitors tend to be less effective than TCS or TCI. Local application-site reactions are more common with TCI and crisaborole than with TCS. Overall, potent TCS, JAK inhibitors, and tacrolimus 0.1% are among the most effective topical anti-inflammatory treatments, while mild TCS and tapinarof 1% are less effective 1356+2 MORE.
Non-Pharmacological Topical Treatments: Emollients, Cleansers, and Barrier Creams
Basic therapy for eczema always includes hydrating and barrier-stabilizing topical treatments, such as emollients, cleansers, and barrier creams. These products help repair the skin barrier, reduce dryness, and prevent flare-ups. Proper use of these non-pharmacological treatments is essential for effective management and can reduce the need for anti-inflammatory medications. However, inadequate prescription or use can make these products less effective or even counterproductive. Guidelines emphasize the importance of selecting the right product and using it correctly to maximize benefits 2689.
Phytochemical-Based and Botanical Topical Treatments
There is growing interest in phytochemical-based and botanical topical treatments for eczema, such as creams containing plant extracts or oils. Some plant-based products have shown anti-inflammatory effects, improved skin barrier function, and reduced itching and dryness in both clinical and animal studies. These natural treatments may help reduce the long-term side effects associated with conventional topical drugs. However, robust clinical evidence is still limited, and more well-designed trials are needed to confirm their safety and effectiveness 47.
Safety and Adverse Effects of Topical Treatments
Short-term use of topical corticosteroids is generally safe, with a low risk of skin thinning or other local adverse effects. The risk of skin thinning increases with higher potency and longer-term use. Topical calcineurin inhibitors and crisaborole are more likely to cause local application-site reactions, such as burning or stinging, but do not cause skin thinning. Pigmentation changes are rare with both TCS and crisaborole. Monitoring for side effects is important, especially with prolonged or high-potency treatments 15.
Practical Considerations and Patient Education
Effective eczema management requires individualized treatment plans that consider disease severity, patient age, and specific skin areas affected. Education on correct use of topical treatments, including when and how to apply them, is crucial for achieving the best outcomes. Proactive therapy with intermittent use of anti-inflammatory agents can help prevent relapses in frequently affected areas. Patient education programs and clear communication about treatment strategies are recommended for both children and adults 68910.
Conclusion
Topical treatments for eczema include a range of anti-inflammatory medications—primarily corticosteroids and calcineurin inhibitors—as well as non-pharmacological options like emollients and barrier creams. Potent TCS, JAK inhibitors, and tacrolimus 0.1% are among the most effective for controlling symptoms, while milder agents and some newer drugs are less effective. Non-pharmacological treatments are essential for maintaining skin barrier health and preventing flares. Botanical and phytochemical-based treatments show promise but require more evidence. Safety is generally good with short-term use of most topical agents, but monitoring and patient education are key to minimizing risks and maximizing benefits.
Sources and full results
Most relevant research papers on this topic